• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know
Life Technologies is a global biotechnology tools company. Co. provides a range of products and services, including systems, instruments, reagents, and custom services. Co.'s portfolio of products includes technologies for capillary electrophoresis based sequencing, polymerase chain reaction, sample preparation, cell culture, ribonucleic acid interference analysis, functional genomics research, proteomics and cell biology applications, as well as clinical diagnostic applications, forensics, animal, food, pharmaceutical and water testing analysis. Co. operates its business under four divisions: Molecular Biology Systems; Genetic Systems; Cell Systems; and Mass Spectrometry.
Please sign in first
none
none
none
| Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
|---|---|---|---|---|
|
No longer subject to file | 2014-02-03 | 0 | |
|
No longer subject to file | 2014-02-03 | 0 | |
|
No longer subject to file | 2014-02-03 | 0 | |
|
No longer subject to file | 2014-02-03 | 0 | |
|
COTTINGHAM JOHN A CHIEF LEGAL OFFICER |
|
No longer subject to file | 2014-02-03 | 0 |
|
No longer subject to file | 2014-02-03 | 0 | |
|
No longer subject to file | 2014-02-03 | 0 | |
|
No longer subject to file | 2014-02-03 | 0 | |
|
No longer subject to file | 2014-02-03 | 0 | |
|
LUCIER GREGORY T CHIEF EXECUTIVE OFFICER |
|
No longer subject to file | 2014-02-03 | 0 |
|
RICHARD KELLI CHIEF ACCOUNTING OFFICER |
|
No longer subject to file | 2014-02-03 | 0 |
|
ANDREWS RONALD ASBURY PRESIDENT, MEDICAL SCIENCES |
|
No longer subject to file | 2014-02-03 | 0 |
|
HOFFMEISTER DAVID F CHIEF FINANCIAL OFFICER |
|
No longer subject to file | 2014-02-03 | 0 |
|
LEDDY PETER MICHAEL SVP, GLOBAL HUMAN RESOURCES |
|
No longer subject to file | 2014-02-03 | 0 |
|
STEVENSON MARK PRESIDENT & COO |
|
No longer subject to file | 2014-02-03 | 0 |
|
No longer subject to file | 2014-02-03 | 0 | |
|
No longer subject to file | 2013-04-25 | 0 | |
|
No longer subject to file | 2013-04-24 | 0 | |
|
No longer subject to file | 2012-04-26 | 0 | |
|
BEERY JOSEPH C SVP, CHIEF INFORMATION OFFICER |
|
No longer subject to file | 2011-05-02 | 0 |
|
BARTHELEMY NICOLAS PRES, COMMERCIAL OPERATIONS |
|
No longer subject to file | 2011-05-02 | 0 |
|
MILLER JOHN L PRESIDENT, GENETIC SYSTEMS |
|
No longer subject to file | 2011-05-02 | 0 |
|
BRUST BERND PRESIDENT, MOLECULAR MEDICINE |
|
No longer subject to file | 2011-05-02 | 0 |
|
GROSSMAN PAUL DAVID SVP, CORPORATE STRATEGY & DEV. |
|
No longer subject to file | 2011-05-02 | 0 |
|
DANSKY PETER PRES, MOLECULAR BIOLOGY SYS |
|
No longer subject to file | 2011-05-02 | 0 |
|
O'DONNELL MARK SEAN SVP, GLOBAL OPS & SERVICES |
|
No longer subject to file | 2011-05-02 | 0 |
|
No longer subject to file | 2011-04-28 | 0 | |
|
0 | 2010-04-29 | 0 | |
|
BENCHIMOL CLAUDE SVP, ADVANCED GENOMIC SYSTEMS |
|
No longer subject to file | 2008-11-21 | 0 |
|
No longer subject to file | 2008-05-01 | 0 | |
|
GIBSON KAREN CHIEF INFORMATION OFFICER |
|
No longer subject to file | 2008-04-25 | 0 |
|
THOMPSON JOHN D SVP, CORPORATE DEVELOPMENT |
|
6,617 | 2007-07-10 | 0 |
|
RADAK JOHN MATTHEW VP FINANCE & ACCOUNTING |
|
1,806 | 2007-02-28 | 0 |
|
BULKLEY BENJAMIN SR. VP GLOBAL COMMERCIAL OPS |
|
60,821 | 2007-02-14 | 0 |
|
HINDAR JON SVP LIFE SCIENCES DIVISION |
|
0 | 2006-06-13 | 0 |
|
0 | 2006-04-26 | 0 | |
|
FAULKNER DARYL SENIOR VICE PRESIDENT |
|
0 | 2006-01-06 | 0 |
| Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| No current insider transactions | ||||||||||||||||
* -
| Code | Definition |
|---|---|
| A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
| C | Conversion of derivative security |
| D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
| G | Bona fide gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
| J | Other acquisition or disposition |
| L | Small acquisition under Rule 16a-6 |
| M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
| O | Exercise of out-of-the-money derivative security |
| P | Open market or private purchase of non-derivative or derivative security |
| S | Open market or private sale of non-derivative or derivative security |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| W | Acquisition or disposition by will or the laws of descent and distribution |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
| Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
|---|
| Holder | Issuer | Net Short Position | Position Date | Origin |
|---|
